학술논문

Multi-institutional validation of a modified scheme for subcategorizing salivary gland neoplasm of uncertain malignant potential (SUMP)
Document Type
Report
Source
Cancer Cytopathology. July, 2022, Vol. 130 Issue 7, p511, 12 p.
Subject
Tumors
Health
Language
English
ISSN
1934-662X
Abstract
Keywords: basaloid; Milan System for Reporting Salivary Gland Cytopathology (MSRSGC); oncocytic/oncocytoid; salivary gland neoplasm of uncertain malignant potential (SUMP); subcategory BACKGROUND The salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan System is diagnostically challenging. This study aims to validate a modified scheme for subcategorizing SUMP in a large multi-institutional cohort. METHODS Retrospective review of salivary gland fine-needle aspirations (FNAs) from 10 institutions were classified based on the Milan System. Cases diagnosed as SUMP with available cytology slides and surgical follow-up were retrieved for review and subcategorized based on a modified scheme as follows: basaloid SUMP (B1: absent/scant nonfibrillary matrix; B2: presence of nonfibrillary/mixed-type matrix), oncocytic/oncocytoid SUMP (O1: with mucinous background; O2: without mucinous background), and SUMP not otherwise specified (NOS). RESULTS A total of 742 (7.5%) cases from 9938 consecutive salivary gland FNAs were classified as SUMP. Among them, 525 (70.8%) had surgical follow-up and 329 (62.7%) were available for review. The overall risk of malignancy (ROM) of SUMP was 40.4%. There were 156 cases (47.4%) subcategorized as basaloid SUMP with a ROM of 36.5%, 101 (30.7%) as oncocytic/oncocytoid SUMP with a ROM of 52.5%, and 72 (21.9%) as SUMP NOS with a ROM of 31.9%. The ROM of oncocytic/oncocytoid SUMP was significantly higher than basaloid SUMP (P = .0142) and SUMP NOS (P = .0084). No significant differences in ROM were noted between B1 and B2 (36.7% vs 36.4%, P = 1.0000) and O1 and O2 (65.2% vs 48.7%, P = .2349). CONCLUSIONS The ROM of oncocytic/oncocytoid SUMP was 52.5% and significantly higher than that of basaloid SUMP (36.5%, P = .0142) and SUMP NOS (31.9%, P = .0084), whereas no significant differences in ROM were noted for cases with different types of extracellular matrix or background material.; Article Note: See referenced original article on pages 484-487, this issue. Byline: Jen-Fan Hang, Jaslyn Jie Lin Lee, Min En Nga, Kayoko Higuchi, Yukiya Hirata, Howard H. Wu, Derek B. Allison, Jason D. Gilbert, Oscar Lin, Mauro Saieg, Arthur Ferrari de Arruda, Yun-An Chen, Eric C. Huang, Varsha Manucha